Virus Filtration:
Virus filtration is paramount for ensuring the virus safety of biopharmaceutical products. Our solutions are designed to meet stringent regulatory requirements, providing reliable and efficient virus removal. By maintaining low-shear and low-pulsation conditions , our systems help ensure that biologic products are free from viral contaminants, safeguarding patient health.
Shear-Sensitive Products:
Many biopharmaceutical products, such as monoclonal antibodies, vaccines and gene therapies, are highly sensitive to shear forces. Our Quattroflow pumps are specifically engineered to handle these shear-sensitive products with care, minimizing the risk of denaturation and maintaining product efficacy throughout the filtration process.
Vaccine Production:
In vaccine production, maintaining the integrity of viral particles is crucial. Our low-shear, low-pulsation pumping solutions ensure that viral vectors and antigens are preserved during filtration, enhancing the quality and effectiveness of vaccines.
Therapeutic Protein Purification:
Virus filtration is a key step in the purification of therapeutic proteins. Our advanced filtration systems provide the precision and reliability needed to remove viral contaminants while preserving the biological activity of proteins. This is particularly important for ensuring the potency and safety of therapeutic products.
Gene Therapy Manufacturing:
In gene therapy, viral vectors are used to deliver genetic material to target cells. Ensuring the purity and integrity of these viral vectors is critical for the success of gene therapies. Our virus filtration solutions offer the necessary control and precision to achieve high levels of viral vector purity, supporting the development of safe and effective gene therapies.
Continuous Processing:
Our virus filtration systems are designed to support both batch and continuous processing, providing flexibility to meet varying production demands. Continuous processing enhances operational efficiency and scalability, allowing for the production of larger quantities of biopharmaceutical products without compromising quality.